Oligon™ is an emerging biotechnology company developing a novel class of multimodal RNA therapeutics that can simultaneously silence numerous disease targets with a single RNA molecule to improve outcomes and combat emerging drug resistance. Our proprietary SeekR™ platform is used to digitally engineer and rapidly produce self-delivering therapeutics which target specific tissues with unprecedented precision and accuracy. We are focused on building a pipeline of products in oncology, yet our multimodal RNA platform can be harnessed to transform outcomes for any complex multigenic disease.
Company Details
- Employees
- 2
- Address
- 7201 E Henkel Way,
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.Oligon.com
- Keywords
- Scottsdale.
- HQ
- Scottsdale, Arizona
Oligon Questions
Oligon's website is http://www.Oligon.com
Oligon's LinkedIn profile is https://www.linkedin.com/company/oligon-inc
Oligon has
2 employees.
View email and phone details for 2
employees at Oligon.
Oligon's industry is
Biotechnology Research
Oligon's top competitors are
Caris Life Sciences,
Td2 Oncology,
Genosensor Corporation,
Phoenix Bioscience Core,
Calviri,
Systems Imagination, Inc.,
Oncomyx Therapeutics,
Humabiologics®, Inc,
Systems Oncology,
Amnio Technology.
Oligon's categories are Biotechnology Research
